| |
| |
|
| Insider
Information: |
Coulie Bernard |
| Relationship: |
President and CEO, Dir... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
444,532 |
|
|
Indirect Shares
|
409,317 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
853,849 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pliant Therapeutics, Inc. |
PLRX |
President and CEO, Dir... |
2024-01-23 |
444,532 |
2024-01-23 |
409,317 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
56 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PLRX |
Pliant Therapeutics, Inc. |
President and CEOOfficer |
• • – |
2020-06-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
48,840 |
|
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEOOfficer |
• • – |
2020-06-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
448,920 |
|
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2020-04-30 |
4 |
OE |
$2.08 |
$104,125 |
D/D |
48,840 |
48,840 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2020-06-05 |
4 |
A |
$0.00 |
$0 |
I/I |
25,397 |
474,317 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2020-12-14 |
4 |
AS |
$27.32 |
$95,790 |
I/I |
(3,500) |
470,817 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2021-01-14 |
4 |
AS |
$26.20 |
$92,325 |
I/I |
(3,500) |
467,317 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2021-02-16 |
4 |
AS |
$32.10 |
$114,352 |
I/I |
(3,500) |
463,817 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2021-03-15 |
4 |
AS |
$38.03 |
$134,835 |
I/I |
(3,500) |
460,317 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2021-04-13 |
4 |
OE |
$2.08 |
$12,480 |
D/D |
6,000 |
54,840 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2021-04-14 |
4 |
AS |
$30.33 |
$106,161 |
I/I |
(3,500) |
456,817 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2021-05-14 |
4 |
AS |
$28.53 |
$100,224 |
I/I |
(3,500) |
453,317 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2021-06-14 |
4 |
AS |
$32.98 |
$132,102 |
I/I |
(4,000) |
449,317 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2022-07-11 |
4 |
OE |
$2.08 |
$31,200 |
D/D |
15,000 |
74,273 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2022-07-11 |
4 |
AS |
$22.50 |
$337,500 |
D/D |
(15,000) |
59,273 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2022-07-12 |
4 |
AS |
$22.50 |
$281,205 |
D/D |
(12,498) |
59,273 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2022-07-12 |
4 |
OE |
$2.08 |
$25,996 |
D/D |
12,498 |
71,771 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2022-09-12 |
4 |
OE |
$2.08 |
$26,004 |
D/D |
12,502 |
71,775 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2022-09-12 |
4 |
AS |
$22.54 |
$281,851 |
D/D |
(12,502) |
59,273 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2022-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
68,751 |
128,024 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2022-12-20 |
4 |
S |
$19.10 |
$653,531 |
D/D |
(34,212) |
93,812 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-01-03 |
4 |
OE |
$2.08 |
$31,200 |
D/D |
15,000 |
108,812 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-01-03 |
4 |
AS |
$19.33 |
$289,952 |
D/D |
(15,000) |
93,812 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-01-04 |
4 |
AS |
$19.06 |
$285,941 |
D/D |
(15,000) |
93,812 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-01-04 |
4 |
OE |
$2.08 |
$31,200 |
D/D |
15,000 |
108,812 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
President and CEO |
• • – |
2023-01-06 |
4 |
OE |
$2.08 |
$31,200 |
D/D |
15,000 |
108,812 |
0 |
- |
|
56 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
